Advertisement

Psychopharmacology

, Volume 80, Issue 1, pp 14–18 | Cite as

Tricyclic plasma levels in depressed outpatients treated with amitriptyline

  • Karl Rickels
  • Charles Weise
  • George Case
  • Howard Hucker
Original Investigations

Abstract

Seventy-four patients were treated with 150 mg/day amitriptyline (AT) to determine possible correlations between clinical improvement, demographic variables, and AT and nortriptyline (NT) plasma levels. Plasma level determinations after 2 and 6 weeks of treatment revealed that moderately significant correlations existed between AT plasma levels and clinical improvement, dosage intake, age, weight, sex, and coffee intake. Some of these findings were more pronounced after 2, and some after 6 weeks of treatment.

Key words

Tricyclic antidepressant Plasma level Amitriptyline Nortriptyline Clinical improvement Depression Psychopathology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association (1980) DSM-III: Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC, pp 205–224Google Scholar
  2. Amin MM, Cooper R, Khalid R, Lehmann HE (1978) A comparison of desipramine and amitriptyline plasma levels and therapeutic response. Psychopharmacol Bull 14: 45–46Google Scholar
  3. Amsterdam J, Brunswick D, Mendels J (1980) The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 137: 653–662Google Scholar
  4. Braithwaite RA, Goulding R, Theano G, Bailey J, Coppen A (1972) Plasma concentration of amitriptyline and clinical response. Lancet 1: 1297–1300Google Scholar
  5. Coppen A, Montgomery S, Ghose K, Rama Rao VA, Bailey J (1978) Amitriptyline plasma-concentration and clinical effect. Lancet 1: 63–66Google Scholar
  6. Corona GL, Pinelli P, Zerbi F, Fenoglio L, Santagostino G, Frattini P, Cucchi ML (1980) Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders. Pharmakopsychiatrie 13: 102–110Google Scholar
  7. Downing RW, Rickels K (1982) Coffee consumption, cigarette smoking and the reporting of drowsiness in anxious patients treated with benzodiazepines or placebo. Acta Psychiatr Scand 64: 398–408Google Scholar
  8. Draper NR, Smith H (1981) Applied regression analysis. John Wiley and Sons, New York, 299–300Google Scholar
  9. Dutt JE (1981) On the clinical response-serum level relationship for antidepressants. I. Amitriptyline. Psychopharmacol Bull 17: 42–55Google Scholar
  10. Giedke H, Gaetner H, Breyer-Pfaff U (1980) Plasma levels of amitriptyline and nortriptyline, clinical response and psychophysiological variables in depression. Drug Res 30: 1201Google Scholar
  11. Hamilton MA (1960) Rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62Google Scholar
  12. Hucker HB, Stauffer SC (1977) Rapid, sensitive gas-liquid chromatographic method for determination of amitriptyline and nortriptyline in plasma using a nitrogen-sensitive detector. J Chromatogr 138: 437–442Google Scholar
  13. Johnstone EC, Bourne RC, Crow TJ, Frith CD, Gamble S, Lofthouse R, Owen F, Owens DGC, Robinson J, Stevens M (1981) The relationship between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients. Psychopharmacology 72: 233–240Google Scholar
  14. Jungkunz G, Kuss HJ (1980) On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline-treated depressive patients. Pharmakopsychiatrie 13: 111–116Google Scholar
  15. Kupfer DJ, Hanin I, Spiker DG, Grau T, Coble P (1977) Amitriptyline plasma levels and clinical response in primary depression. Clin Pharmacol Ther 22: 904–911Google Scholar
  16. Kupfer DJ, Hanin I, Spiker D, Neil J, Coble P, Grau T, Nevar C (1978) Amitriptyline plasma levels and clinical response in primary depression. II Commun Psychopharmacol 2: 441–450Google Scholar
  17. Linnoila M, George L, Guthric S, Leventhal B (1981) Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients. Am J Psychiatry 138: 841–842Google Scholar
  18. Mendlewicz J, Linkowski P, Rees JA (1980) A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: Serum levels and clinical response. Br J Psychiatry 136: 154–160Google Scholar
  19. Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134: 790–793Google Scholar
  20. Norman TR, Burrows GD, Maguire KP, Rubinstein G, Scoggins BA, Davies B (1977) Cigarette smoking and plasma nortriptyline levels. Clin Pharmacol Ther 121: 453–456Google Scholar
  21. Raskin A, Schulterbrandt JG, Reating N, McKeon JJ (1970) Differential response to chlorpromazine, imipramine and placebo. Arch Gen Psychiatry 23: 164–173Google Scholar
  22. Rickels K, Downing RW, Spaeth H (1973) The physician depression scale (PDS): A factor analytic study. Pharmakopsychiatr Neuropsychopharmakol 6: 280–286Google Scholar
  23. Risch SC, Huey LY, Janowsky DS (1979) Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. J Clin Psychiatry 40: 4–16Google Scholar
  24. Robinson DS, Cooper TB, Ravaris CL, Ives JO, Nies A, Bartlett D, Lamborn KR (1979) Plasma tricyclic drug levels in amitriptylinetreated depressed patients. Psychopharmacology 63: 223–231Google Scholar
  25. Weise CC, Stein MK, Pereira-Ogan J, Csanalosi I, Rickels K (1980) Amitriptyline once daily vs. three times daily in depressed outpatients. Arch Gen Psychiatry 37: 555–560Google Scholar
  26. Ziegler VE, Biggs JT (1977) Tricyclic plasma levels: Effect of age, race, sex, and smoking. JAMA 238: 2167–2169Google Scholar
  27. Ziegler VE, Clayton PJ, Biggs JT (1977) A comparison study of amitriptyline and nortriptyline with plasma levels. Arch Gen Psychiatry 34: 607–612Google Scholar
  28. Ziegler VE, Co BT, Taylor JR, Clayton PJ, Biggs JT (1976) Amitriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 19: 795–801Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • Karl Rickels
    • 1
  • Charles Weise
    • 1
  • George Case
    • 1
  • Howard Hucker
    • 2
  1. 1.Department of Psychiatry, Psychopharmacology Research and Treatment Unit and Private Practice Research GroupUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Merck, Sharp and DohmeWest PointUSA

Personalised recommendations